Purpose: To evaluate cognitive and academic functioning in survivors of ped
iatric bone marrow transplants (BMTs) at 1 and 3 years after a BMT.
Patients and Methods: In a prospective, longitudinal design, patients under
went a comprehensive battery of neurocognitive measures before admission fo
r transplantation and at 1, 3, and 5 years after a BMT, This article descri
bes a cohort of 102 survivors with follow-up data available for 1 year afte
r a BMT, including 54 survivors with follow-up available for 3 years. This
represents the largest cohort of pediatric BMT survivors yet reported in a
prospective study.
Results: In the cohort as a whole, there were no significant changes on glo
bal measures of intelligence (intelligence quotient [IQ]) and academic achi
evement at either 1 or 3 years after a BMT, despite adequate power to detec
t an IQ change of three points or greater, Likewise, performance on specifi
c tests of neuropsychologic function remained stable. No significant differ
ences were observed between patients whose conditioning regimen included to
tal-body irradiation (TBI) and those whose did not, The primary predictor o
f neurocognitive outcome was patient age, with younger patients more likely
to show declines over time. The subset of patients who were less than 3 ye
ars of age at the time of transplantation seemed to be particularly vulnera
ble to cognitive sequelae,
Conclusion: The use of BMTs with or without TBI entails minimal risk of lat
e neurocognitive sequelae in patients who are 6 years of age or older at th
e time of transplantation. However, patients who are less than 6 years of a
ge at the time of transplantation, and particularly those less than 3 years
of age, seem to be at some risk of cognitive declines, J Clin Oncol 18:100
4-1011, (C) 2000 by American Society of Clinical Oncology.